Excellent Outcomes With High‐Risk Pediatric Hepatoblastoma: A Detailed Analysis of a Large, Single‐Center Experience
Pediatric Transplantation · 2026
DOI: 10.1111/petr.70354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Valeria Ripa und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of California, Los Angeles, Transplant Surgery, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Hepatoblastoma, Liver Transplantation, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hepatoblastoma (HBA) is a rare pediatric malignancy treatable with liver transplantation (LTx). Limited data exist on outcomes after LTx for HBA. This study evaluates the therapeutic efficacy of LTx in pediatric patients with HBA, delineates principal complications, and assesses long‐term psychosocial outcomes.
Methods
This retrospective cohort study analyzed a prospectively maintained database of children undergoing LTx for HBA at a single US center from 1984 to 2025. Primary outcomes were patient and graft survival at 1, 5, and 10 years post‐LTx and HBA recurrence. Secondary outcomes included post‐LTx complications, recurrence predictors, and psychosocial parameters.
Results
Of 55 patients (60% female; 40% Hispanic; mean age at diagnosis, 36 months), most had PRETEXT stage III (44%) or IV (47%) disease; mean α‐fetoprotein level at diagnosis was 569 355 ng/mL. All but 1 received chemotherapy; 15 (27%) had pre‐LTx resection. Mean wait time to LTx was 10 months. Pre‐LTx metastatic disease (pulmonary) was present in 5 patients (9%). Explant pathology showed macrovascular invasion ( n = 16), positive lymph nodes ( n = 3), and extra‐hepatic tumor invasion/rupture ( n = 2). Post‐LTx complications included HBA recurrence (20%), hepatic artery thrombosis (11%), and biliary stricture (20%). Patient survival was 89% at 1 year, 74% at 5 and 10 years; graft survival was 89%, 73%, and 73%, respectively. Significant predictors of recurrence were older age at LTx ( p = 0.01), longer waiting time to LTx ( p = 0.02), prior resection ( p = 0.01), larger tumor size ( p = 0.03), vascular invasion ( p = 0.02), and utilization of a segmental graft ( p = 0.002). Mortality was mainly due to recurrence. Psychosocially, 14 patients needed special education, 10 had developmental delays, 5 of 12 adults completed high school, 2 earned college degrees, and 3 are employed.
Conclusion
This large single‐center study demonstrates favorable survival after LTx for high‐risk HBA. Recurrence predictors support avoiding pre‐LTx resection in high‐risk cases. While living donor or split grafts can expedite transplantation, segmental grafts were independently linked to higher recurrence. Notably, metastases at diagnosis did not increase recurrence, supporting aggressive treatment. The rate of HAT and biliary stricture was significantly higher for children transplanted for HBA than for our overall pediatric experience. These findings help guide the management of this rare malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of California, Los Angeles, Transplant Surgery, Los Angeles, California, USA.
- University of California, Los Angeles, Pediatric Gastroenterology, Los Angeles, California, USA.
ORCID-Profile: Jonathan Jou
Zitieren
APA
Ripa, V., Venick, R. S., Ebaid, S., Federman, N., Charland, N., Thornley, C. J., Jou, J., Pearson, B., Agopian, V. G., Kaldas, F. M., McDiarmid, S. V., & Farmer, D. G. (2026). Excellent Outcomes With High‐Risk Pediatric Hepatoblastoma: A Detailed Analysis of a Large, Single‐Center Experience. Pediatric Transplantation. https://doi.org/10.1111/petr.70354
Vancouver
Ripa V, Venick RS, Ebaid S, Federman N, Charland N, Thornley CJ, et al. Excellent Outcomes With High‐Risk Pediatric Hepatoblastoma: A Detailed Analysis of a Large, Single‐Center Experience. Pediatric Transplantation. 2026. doi:10.1111/petr.70354
BibTeX
@article{Ripa2026,
author = {Ripa, Valeria and Venick, Robert S and Ebaid, Samer and Federman, Noah and Charland, Nicole and Thornley, Caitlin J and Jou, Jonathan and Pearson, Brandon and Agopian, Vatche G and Kaldas, Fady M and McDiarmid, Suzanne V and Farmer, Douglas G},
title = {Excellent Outcomes With High‐Risk Pediatric Hepatoblastoma: A Detailed Analysis of a Large, Single‐Center Experience},
journal = {Pediatric Transplantation},
year = {2026},
doi = {10.1111/petr.70354}
}
EUVIMED